Unlock instant, AI-driven research and patent intelligence for your innovation.

Nitric oxide donating hypoglycemic compound, its preparation method and use

A technology of compounds and intermediates, applied in the field of hypoglycemic compounds and their preparation, and the preparation of hypoglycemic drugs, which can solve the problems of large gastrointestinal damage, indigestion, poor tolerance drug interactions, etc., and achieve obvious inhibitory effect Effect

Active Publication Date: 2016-06-01
TIANJIN INSTITUTE OF PHARMA RESEARCH
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the biggest side effect of many drugs is hypoglycemia. In addition, there are poor tolerance and drug interactions. Long-term use will cause great damage to the gastrointestinal tract and easily cause indigestion.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nitric oxide donating hypoglycemic compound, its preparation method and use
  • Nitric oxide donating hypoglycemic compound, its preparation method and use
  • Nitric oxide donating hypoglycemic compound, its preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] 2-(3-(3-(piperidin-1-ylmethyl)phenoxy)propylamino)-2-oxoethyl nitrate (compound Ⅰ-1)

[0074]

[0075] Add intermediate V-1 (3.2g, 0.01mol) in the reaction flask equipped with stirring, condenser and thermometer, dissolve in anhydrous acetonitrile (20m1), add anhydrous acetonitrile solution of silver nitrate (2.0g, 0.012mol) (10m1), refluxed for 5h under stirring in the dark, TLC showed that the reaction was complete and cooled to room temperature, and the solvent was evaporated to dryness under reduced pressure. Dichloromethane (20ml) was added to the residue, stirred for 10min, filtered, and the filtrate was evaporated to dryness under reduced pressure. Add absolute ethanol (30ml), decolorize with activated carbon, evaporate to dryness under reduced pressure, and dry under reduced pressure at room temperature overnight to obtain light yellow transparent oil I-1 (3.1g, yield 90%), purity 98.2% (HPLC method). MS (m / z): 351.

[0076] Referring to the method of Examp...

Embodiment 2

[0079] 2-(3-(3-(piperidin-1-ylmethyl)phenoxy)propylamino)ethyl nitrate (compound Ⅰ-4)

[0080]

[0081] Mix 6.5ml of fuming nitric acid and 19.5ml of acetic anhydride in a reaction flask equipped with stirring, condenser, and thermometer, control the temperature at -15°C, and add intermediate VI-1 (2.9g, 0.01mol) dropwise Tetrahydrofuran solution 100mL, after dropping, slowly rise to room temperature, react for 4h, add dropwise ice water to stop the reaction. The reaction mixture was dissolved in 200ml of ethyl acetate, washed successively with 200ml of water, 200ml of saturated sodium bicarbonate solution, and then washed with 200ml of water and 200ml of saturated sodium chloride solution. The organic layer was dried over anhydrous magnesium sulfate. Concentrated under reduced pressure, the crude product was purified by column chromatography (v (petroleum ether): v (ethyl acetate) = 1:1] to obtain 1.9 g of yellow oil with a yield of 58% and a purity of 99.1%. MS (m / z ): ...

Embodiment 3

[0085] Compound Ⅰ-2 into hydrochloride: Take 1.5 g of compound Ⅰ-2 yellow oil and dissolve it in 10 mL of absolute ethanol. Cool in an ice-water bath to 5°C, add 11.1% ethanol hydrochloric acid solution dropwise until the pH is 2, and continue stirring for about 1 h in an ice-water bath. Filter and dry in vacuo to obtain a yellow solid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of hypoglycemic drugs and provides a nitric oxide donor compound with the general formula I and a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are defined as in the specifications. The invention also relates to a preparation of the compound and discloses a medicine composition using the compound or the pharmaceutically acceptable salt thereof as an active ingredient, and purpose thereof in the preparation of hypoglycemic drugs.

Description

technical field [0001] The invention belongs to the technical field of medicine, more specifically, relates to a class of compounds capable of lowering blood sugar, a preparation method thereof, a pharmaceutical composition containing them and the use of preparing hypoglycemic drugs. Background technique [0002] In the past 20 years, the incidence of diabetes in China has continued to rise, and China has become the second largest country in the world in the number of diabetic patients, second only to India. In 2009, the Ministry of Human Resources and Social Security released the latest "Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog", which included 18 varieties of insulin and drugs that affect blood sugar growth. Among them: there are 13 oral blood sugar regulating drugs, covering the main products of sulfonylureas, biguanides, α-glucosidase inhibitors, thiazolidinediones and new insulin secretagogues (glinides) listed in China. Varie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D295/096A61K31/4453A61P3/10
CPCC07D295/096
Inventor 刘登科刘颖解晓帅祁浩飞张大帅魏巍邹美香
Owner TIANJIN INSTITUTE OF PHARMA RESEARCH